Activation is a prospective randomised (1 :1) controlled study to test the hypothesis that revascularisation of significant coronary artery disease by Percutaneous Coronary Intervention prior to Transcatheter Aortic Valve Implantation (TAVI) will result in rate of mortality and re-hospitalisation at 12 months that is non-inferior to TAVI without such revascularisation.
Sponsor
Primary endpoints
Composite of mortality and rehospitalisation at 12 months
CERC Services
- Clinical trial documentation
- Regulatory submissions
- Set-up activities (sites selection, insurance management, contract management)
- Monitoring activities
- CEC and DSMB activities
- Clinical report
Countries
France, Germany, United Kingdom
Number of investigational sites
17
Number of patients
235
